These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 39012436)

  • 1. CRISPR beyond: harnessing compact RNA-guided endonucleases for enhanced genome editing.
    Wang F; Ma S; Zhang S; Ji Q; Hu C
    Sci China Life Sci; 2024 Jul; ():. PubMed ID: 39012436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox.
    Koonin EV; Gootenberg JS; Abudayyeh OO
    Biochemistry; 2023 Dec; 62(24):3465-3487. PubMed ID: 37192099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-mediated gene therapies by miniature gene editing tools.
    Kong X; Li T; Yang H
    Sci China Life Sci; 2024 Sep; ():. PubMed ID: 39388062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guide RNA engineering enables efficient CRISPR editing with a miniature Syntrophomonas palmitatica Cas12f1 nuclease.
    Wang Y; Wang Y; Pan D; Yu H; Zhang Y; Chen W; Li F; Wu Z; Ji Q
    Cell Rep; 2022 Sep; 40(13):111418. PubMed ID: 36170834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems.
    Aquino-Jarquin G
    Drug Discov Today; 2023 Nov; 28(11):103793. PubMed ID: 37797813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transposons and CRISPR: Rewiring Gene Editing.
    Tenjo-Castaño F; Montoya G; Carabias A
    Biochemistry; 2023 Dec; 62(24):3521-3532. PubMed ID: 36130724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent application of CRISPR-Cas12 and OMEGA system for genome editing.
    Badon IW; Oh Y; Kim HJ; Lee SH
    Mol Ther; 2024 Jan; 32(1):32-43. PubMed ID: 37952084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
    Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
    Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cas12n nucleases, early evolutionary intermediates of type V CRISPR, comprise a distinct family of miniature genome editors.
    Chen W; Ma J; Wu Z; Wang Z; Zhang H; Fu W; Pan D; Shi J; Ji Q
    Mol Cell; 2023 Aug; 83(15):2768-2780.e6. PubMed ID: 37402371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
    Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
    Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
    Yu C; Mo J; Zhao X; Li G; Zhang X
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in base editing systems].
    Zhong J; Lin J; Zhou J; Qiao Y
    Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1271-1292. PubMed ID: 38783797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in CRISPR-Cas-mediated genome editing system in plants].
    Wang C; Wang K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1712-1722. PubMed ID: 29082719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fanzor is a eukaryotic programmable RNA-guided endonuclease.
    Saito M; Xu P; Faure G; Maguire S; Kannan S; Altae-Tran H; Vo S; Desimone A; Macrae RK; Zhang F
    Nature; 2023 Aug; 620(7974):660-668. PubMed ID: 37380027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing.
    Xu X; Chemparathy A; Zeng L; Kempton HR; Shang S; Nakamura M; Qi LS
    Mol Cell; 2021 Oct; 81(20):4333-4345.e4. PubMed ID: 34480847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.
    Anzalone AV; Koblan LW; Liu DR
    Nat Biotechnol; 2020 Jul; 38(7):824-844. PubMed ID: 32572269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the power of directed evolution to improve genome editing systems.
    Su Q; Zhou M; Cheng C; Niu J
    Curr Opin Chem Biol; 2021 Oct; 64():10-19. PubMed ID: 33725650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
    Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
    Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity.
    Tsuchida CA; Zhang S; Doost MS; Zhao Y; Wang J; O'Brien E; Fang H; Li CP; Li D; Hai ZY; Chuck J; Brötzmann J; Vartoumian A; Burstein D; Chen XW; Nogales E; Doudna JA; Liu JG
    Mol Cell; 2022 Mar; 82(6):1199-1209.e6. PubMed ID: 35219382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.